<p>Joe Mannello is the CEO of MYOS CORP, a medical nutrition company based in NJ. Under his leadership, the company has proven its commitment to world-class research with the publication of six clinical studies, received five new US Patents, and has launched successful businesses in both animal health and sports nutrition. In the spring of 2024, MYOS launched a new product line exclusively for the healthcare provider channel. This new product, MYOS MD, is powered by the company&#8217;s proprietary ingredient, Fortetropin, and works to help reduce the muscle loss associated with aging, disuse, and/or medical treatment, like GLP-1 medications.</p>
